Location: Home > Pharma China Web Edition
  • search
  • go
  • Feature Articles
  • 10/26/2023Patent Linkage In China: What Do The First Decisions Tell Us About The...
  • 10/24/2023Infographic: Rare diseases in China (Research Partnership)
  • 10/17/2023China: The New Frontier for Western CDMOs? (Contract Pharma)
  • 10/15/2023The Rising Importance of Patient Advocacy Innovations in Asia (PharmEx...
  • 10/15/2023Pfizer CEO Albert Bourla Wants To Tap 'Chinese Science' As The Drug Co...
  • 10/12/2023China's Vast Opportunities In Health Care Attract Global Telemedicine ...
  • 10/10/2023China Market Opportunities for International Pharmas (Lek)
  • 10/9/2023MNCs Wary of Pouring Big Investments in China While Actively Seeking L...
  • 10/3/2023As Another New Normal of China Healthcare Dawns, Pharma MNCs Need to C...
  • 9/28/2023Overview of Recent Anti-Corruption Enforcement Actions in the Pharmace...
  • 9/26/2023AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happe...
  • 9/26/2023Patent Linkage In China: What The First Decisions Reveal About The Dir...
  • 9/24/2023Improving Access to Medicines and Beyond: the National Volume-based Pr...
  • 9/24/2023Strategies for Asian Business Navigating a New Era (McKinsey)
  • 9/20/2023Chinese Drugmakers Hit a Fundraising and Licensing Slump in August (Ph...
  • 9/19/2023Researchers Must Navigate Thorny New Data Security Laws (UWN)
  • 9/17/2023In China's Changing Economy, MNCs Must Rethink the Mantra of Going Big...
  • 9/15/2023IQVIA: Review of Chinese PD-L1 Drug Market in H1/2023
  • 9/15/2023U.S. and Other Foreign Venture Firms Pull Back From China's Biotech Se...
  • 9/14/2023U.S.-China Track II Dialogue on Healthcare - July 2023 Consensus
  • 9/13/2023Are China's Healthcare and Biopharma Sectors Really Open for Investmen...
  • 9/8/2023Ageing Hong Kong Can Be the Greater Bay Area's Pensions and Healthcare...
  • 8/31/2023China Squeezes Healthcare Swamp with Crackdown and Cost Containment am...
  • 8/31/2023Discussion of Support Issue of Biological Sequence Claims from an Inva...
  • 8/30/2023How to Reduce the Risk of Pharmaceutical Patent Application in China?
  • 8/29/2023Mounjaro's China Approval Imminent as Domestic Competitors Enter Clini...
  • 8/28/2023Regulation of Drug and Medical Device Advertising in China: An Industr...
  • 8/25/2023Patent Linkage in China: What the First Decisions Reveal About the Dir...
  • 8/25/2023China: The Latest Medtech Access Policies and Implications
  • 8/23/2023Increasingly, State Investment and Middle Eastern Sovereign Wealth Are...
  • Page:4/7 Total number of articles:192: [First][<<] [2] [3] [4] [5] [6] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group